| Due Diligence for Asset Managers |
|---|
|
You have viewed 10 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Oragenics Inc | |
|---|---|
| Ticker | OGEN |
| CIK # | 0001174940 |
| CUSIP | 684023609 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 12085 Research Drive, Alachua, FL 32615 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Oragenics Inc | 2023-08-08 | 0.8 M | Exemption: 506(b) · Minimum: $100,000 · Duration: One year or less · Revenue: No Revenues |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001174940] | 10-K | |
| [0001174940] | 10-Q | |
| [0001174940] | 3 | |
| [0001174940] | 4 | |
| [0001174940] | 5 | |
| [0001174940] | 8-K | |
| [0001174940] | D | |
| [0001174940] | SC 13D | |
| [0001174940] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Telling Fred
Common Stock
|
2025-12-12 | Sell | 210 | $0.94 | 197 |
|
Common Stock
|
2025-12-12 | Sell | 210 | $0.94 | 197 |
|
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Gandolfo John P
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Giordano Natasha
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 38,320 | $0.00 | |
|
Pope Charles L
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Telling Fred
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Huffman Janet
Employee Stock Option (right to buy) · derivative
|
2025-12-11 | Grant | 250,000 | $0.00 | |
|
Koski Robert C
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Giordano Natasha
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Dunton Alan W
Non-Employee Director Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 125,000 | $0.00 | |
|
Odyssey Health Inc
Common Stock - OGEN
|
2025-06-18 | Sell | 5,044 | $4.26 | 21,487 |
|
Odyssey Health Inc
Common Stock - OGEN
|
2025-06-17 | Sell | 2,000 | $4.46 | 8,920 |
|
Odyssey Health Inc
Common Stock - OGEN
|
2025-06-16 | Sell | 5,000 | $4.45 | 22,250 |
|
Odyssey Health Inc
Common Stock - OGEN
|
2025-06-13 | Sell | 5,000 | $4.27 | 21,350 |
|
Koski Robert C
Series B Convertible Preferred Stock · derivative
|
2024-12-11 | Conversion | 1,500,000 | ||
|
Koski Robert C
Common Stock
|
2024-12-11 | Conversion | 5,000 | ||
|
Telling Fred
Common Stock
|
2024-12-06 | Sell | 3,597 | $0.36 | 1,295 |
|
Dunton Alan W
Common Stock
|
2024-12-06 | Sell | 66 | $0.36 | 24 |
|
Dunton Alan W
Non-Employee Director Option (Right to Buy) · derivative
|
2024-09-19 | Grant | 65,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 20 | 189,404 |
| 2025-12-31 | 18 | 216,108 |
| 2025-09-30 | 17 | 122,535 |
| 2025-06-30 | 20 | 102,777 |
| 2025-03-31 | 23 | 273,418 |
| 2024-12-31 | 25 | 235,185 |
| 2024-09-30 | 17 | 164,669 |
| 2024-06-30 | 17 | 130,086 |
| 2024-03-31 | 15 | 186,805 |
| 2023-12-31 | 16 | 62,083 |
| 2023-09-30 | 14 | 61,381 |
| 2023-06-30 | 14 | 52,480 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 1 | Prev | Page 1 | Next |